Acknowledgments
Introduction
Mechanism of Action of High-Affinity Antiestrogens An Overview
Pharmacologic and Biologic Properties of Droloxifene, A New Antiestrogen
Induction of Transforming Growth Factor β by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF-7 Cells
Pharmacokinetics of Droloxifene and Its Metabolites in Breast Cancer Patients
Structural Requirements for the in vitro Transformation of Syrian Hamster Embryo Cells by Stilbene Estrogens and Triphenylethylene-Type Antiestrogens
European Early Phase II Dose-Finding Study of Droloxifene in Advanced Breast Cancer
Japanese Early Phase II Study of Droloxifene in the Treatment of Advanced Breast Cancer Preliminary Dose-Finding Study
Droloxifene, A New Antiestrogen Hormonal Influences in Postmenopausal Breast Cancer Patients
Droloxifene, A New Antiestrogen, in Advanced Breast Cancer
Droloxifene-Induced Spikes of Tumor Markers Predict Benefit of Therapy
Summary